Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Soila Sukupolvi-Petty"'
Autor:
Scott A. Smith, A. Ruklanthi de Alwis, Nurgun Kose, Eva Harris, Kristie D. Ibarra, Kristen M. Kahle, Jennifer M. Pfaff, Xiaoxiao Xiang, Benjamin J. Doranz, Aravinda M. de Silva, S. Kyle Austin, Soila Sukupolvi-Petty, Michael S. Diamond, James E. Crowe
Publikováno v:
mBio, Vol 4, Iss 6 (2013)
ABSTRACT Following natural dengue virus (DENV) infection, humans produce some antibodies that recognize only the serotype of infection (type specific) and others that cross-react with all four serotypes (cross-reactive). Recent studies with human ant
Externí odkaz:
https://doaj.org/article/4ebe8688b7984900b3d2b984de558908
Autor:
Katherine L. Williams, Soila Sukupolvi-Petty, Martina Beltramello, Syd Johnson, Federica Sallusto, Antonio Lanzavecchia, Michael S. Diamond, Eva Harris
Publikováno v:
PLoS Pathogens, Vol 9, Iss 3 (2013)
Externí odkaz:
https://doaj.org/article/5de03caf038f435e8dbc910880d4783f
Autor:
Katherine L Williams, Soila Sukupolvi-Petty, Martina Beltramello, Syd Johnson, Federica Sallusto, Antonio Lanzavecchia, Michael S Diamond, Eva Harris
Publikováno v:
PLoS Pathogens, Vol 9, Iss 2, p e1003157 (2013)
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complications following infection with one of the four serotypes of dengue virus (DENV). At present, no vaccine or antiviral therapies are available against dengue. Her
Externí odkaz:
https://doaj.org/article/c78c796ff7084602811749eb968e4d7a
Autor:
Ruklanthi de Alwis, Martina Beltramello, William B. Messer, Soila Sukupolvi-Petty, Wahala M. P. B. Wahala, Annette Kraus, Nicholas P. Olivarez, Quang Pham, James Brian, Wen-Yang Tsai, Wei-Kung Wang, Scott Halstead, Srisakul Kliks, Michael S. Diamond, Ralph Baric, Antonio Lanzavecchia, Federica Sallusto, Aravinda M. de Silva
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 8 (2011)
Externí odkaz:
https://doaj.org/article/a4606288ceb04550a80ffa722bca7778
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.
Autor:
Ruklanthi de Alwis, Martina Beltramello, William B Messer, Soila Sukupolvi-Petty, Wahala M P B Wahala, Annette Kraus, Nicholas P Olivarez, Quang Pham, James D Brien, Wen-Yang Tsai, Wei-Kung Wang, Scott Halstead, Srisakul Kliks, Michael S Diamond, Ralph Baric, Antonio Lanzavecchia, Federica Sallusto, Aravinda M de Silva
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 6, p e1188 (2011)
Humans who experience a primary dengue virus (DENV) infection develop antibodies that preferentially neutralize the homologous serotype responsible for infection. Affected individuals also generate cross-reactive antibodies against heterologous DENV
Externí odkaz:
https://doaj.org/article/c08c8e82c5f44d798389b5216ae750e4
Autor:
Bimmi Shrestha, James D Brien, Soila Sukupolvi-Petty, S Kyle Austin, Melissa A Edeling, Taekyung Kim, Katie M O'Brien, Christopher A Nelson, Syd Johnson, Daved H Fremont, Michael S Diamond
Publikováno v:
PLoS Pathogens, Vol 6, Iss 4, p e1000823 (2010)
Antibody protection against flaviviruses is associated with the development of neutralizing antibodies against the viral envelope (E) protein. Prior studies with West Nile virus (WNV) identified therapeutic mouse and human monoclonal antibodies (MAbs
Externí odkaz:
https://doaj.org/article/df704f99bc524bef9b9a3a5bc6a7a1a1
Autor:
Kimberly A. Dowd, Devika Sirohi, Scott D. Speer, Laura A. VanBlargan, Rita E. Chen, Swati Mukherjee, Bradley M. Whitener, Jennifer Govero, Maya Aleshnick, Bridget Larman, Soila Sukupolvi-Petty, Madhumati Sevvana, Andrew S. Miller, Thomas Klose, Aihua Zheng, Scott Koenig, Margaret Kielian, Richard J. Kuhn, Michael S. Diamond, Theodore C. Pierson
Publikováno v:
Proceedings of the National Academy of Sciences. 120
Cleavage of the flavivirus premembrane (prM) structural protein during maturation can be inefficient. The contribution of partially mature flavivirus virions that retain uncleaved prM to pathogenesis during primary infection is unknown. To investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b37c963a443eeef3f1eb9ffec0c447e
https://doi.org/10.1073/pnas.2218899120
https://doi.org/10.1073/pnas.2218899120
Autor:
Natasha M. Kafai, Lauren E. Williamson, Elad Binshtein, Soila Sukupolvi-Petty, Christina L. Gardner, Jaclyn Liu, Samantha Mackin, Arthur S. Kim, Nurgun Kose, Robert H. Carnahan, Ana Jung, Lindsay Droit, Douglas S. Reed, Scott A. Handley, William B. Klimstra, James E. Crowe, Michael S. Diamond
Publikováno v:
The Journal of experimental medicine. 219(4)
Venezuelan equine encephalitis virus (VEEV) remains a risk for epidemic emergence or use as an aerosolized bioweapon. To develop possible countermeasures, we isolated VEEV-specific neutralizing monoclonal antibodies (mAbs) from mice and a human immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854c83bc12f0c3a171f4b2b0edbdea40
https://pubmed.ncbi.nlm.nih.gov/35297953
https://pubmed.ncbi.nlm.nih.gov/35297953
Autor:
Theodore C. Pierson, Sherri Swayne, Bimmi Shrestha, Daved H. Fremont, Syd Johnson, James D. Brien, Soila Sukupolvi-Petty, Michael S. Diamond, Benjamin J. Doranz, Kristen M. Kahle, S. Kyle Austin
Publikováno v:
Journal of Virology. 87:8826-8842
Although prior studies have characterized the neutralizing activities of monoclonal antibodies (MAbs) against dengue virus (DENV) serotypes 1, 2, and 3 (DENV-1, DENV-2, and DENV-3), few reports have assessed the activity of MAbs against DENV-4. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b9095fc52e29f3f07f2b6487e0ed23
https://doi.org/10.1128/jvi.01314-13
https://doi.org/10.1128/jvi.01314-13
Autor:
Michael A. Schmid, Katherine L. Williams, James D. Brien, Syd Johnson, Soila Sukupolvi-Petty, Michael S. Diamond, Chia-Ying Kao Lam, Eva Harris
Publikováno v:
Journal of Virology. 87:7747-7753
Dengue viruses are the most common arthropod-transmitted viral infection, with an estimated 390 million human infections annually and ∼3.6 billion people at risk. Currently, there are no approved vaccines or therapeutics available to control the gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c921e932e5036477ebb21e240174e88
https://doi.org/10.1128/jvi.00327-13
https://doi.org/10.1128/jvi.00327-13